SEC ownership of EyePoint, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001314102.

Comparable stake leader

Cormorant Asset Management, LP

Disclosed value leader

Cormorant Asset Management, LP

Comparable rows

50/50

Latest evidence

30 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Cormorant Asset Management, LP
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001314102
Issuer location
Watertown, MA

Ownership snapshot

Top shareholders of EyePoint, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Cormorant Asset Managemen...
Disclosed value leader
Cormorant Asset Managemen...
Comparable rows
50/50
Latest evidence
30 Jun 2026
3/4/5 13D/G 13F Lead comparable stake: 8.4% 13D/G row: Cormorant Asset Management, LP Showing 1-8 of 50 holder rows.

Quick read

Cormorant Asset Management, LP leads the comparable SEC ownership view at 8.4%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Cormorant Asset Management, LP's linked filing trail.
Comparable ownership Top 5
Cormorant Asset Management, LP 8.4%
BlackRock, Inc. 7.7%
FEDERATED HERMES, INC. 6.7%
FRANKLIN RESOURCES INC 6.1%
Adage Capital Management, L.P. 5.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Cormorant Asset Management, LP
3/4/5 13D/G 13F
Former 10% Owner · Company
8.4%
from 13D/G
$129,793,560
8,265,000 shares
-$942,240 04 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
7.7%
from 13D/G
$106,723,718
7,463,197 shares
30 Jun 2026
FEDERATED HERMES, INC.
13F 13D/G
Company
6.7%
from 13D/G
$81,239,044
5,681,052 shares
30 Jun 2026
FRANKLIN RESOURCES INC
13F 13D/G
Company
6.1%
from 13D/G
$68,741,215
4,807,078 shares
30 Jun 2026
Adage Capital Management, L.P.
13D/G 3/4/5
10%+ Owner
5.7%
$67,166,904
4,790,792 shares
+$20,900,904 30 Jun 2026
Commodore Capital LP
13F 13D/G
Company
5.1%
from 13D/G
$65,780,000
4,600,000 shares
30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC
13D/G 13F
Vanguard Capital Management · Company
5%
$59,212,278
4,223,415 shares
$0 30 Jun 2026
RA CAPITAL MANAGEMENT, L.P.
13D/G
4.7%
$20,809,090
3,181,818 shares
$0 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$1,969,971.

Buys
$71,982
Insiders: 2
Sells
$2,041,953
Insiders: 3
Net
-$1,969,971
Shares: -115,353
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 12,100 Shares: 127,453
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 10,600 4,875 $52,258 $73,167 -$20,909
3-6 1,500 2,437 $19,724 $36,555 -$16,831
6-9 0 47,419 $0 $807,446 -$807,446
9-12 0 72,722 $0 $1,124,785 -$1,124,785

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 22 reporting-owner rows connected to EyePoint, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
22
Largest Forms 3/4/5 holder
Cormorant Asset Management, LP
Net 12M change
-$1,969,971
Latest report
20 Aug 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Cormorant Asset Management, LP Former 10% Owner $129,793,560 -$942,240 -0.72% Filing P/S 04 Dec 2025
EW Healthcare Partners, L.P. Other*, 10%+ Owner $87,327,483 Mixed 01 Sep 2023
Nancy Lurker Director $7,696,047 -$150,942 -1.9% Mixed 06 Jan 2026
Jay S. Duker President and CEO, Director $2,674,457 +$19,724 +0.74% Median 10 Jul 2026
Therapeutics Ocumension Director $2,507,088 Mixed 11 Jan 2024
Ye Liu Director $2,507,088 Mixed 11 Jan 2024
George Elston Chief Financial Officer $1,751,320 Median 20 Aug 2026
David Scott Jones SVP & Chief Commercial Officer $1,437,581 Mixed 09 Feb 2024
Dario A. Paggiarino Chief Medical Officer $1,386,544 Mixed 30 Mar 2024
Michael Craig Pine Chief Corp Dev.&Strat. Officer $965,391 Mixed 05 Jan 2024
Ramiro Ribeiro Chief Medical Officer $512,120 -$948,771 -65% Mixed 30 Jun 2026
Karen L. Zaderej Director $262,657 +$52,258 +25% Mixed 18 Aug 2026
Douglas Evan Godshall Director $200,525 Mixed 22 Jun 2021
John B. Landis Director $185,752 Mixed 02 Jan 2026
Anthony P. Adamis Director $61,783 Mixed 23 Jun 2024
David R. Guyer Director $18,619 Filing P/S 12 Jul 2024
Wendy F. Dicicco Director Mixed 02 Jan 2026
Fred Hassan Director Mixed 02 Jan 2026
Stuart Duty Director Mixed 02 Jan 2026
Goran Ando Director Mixed 02 Jan 2026

Recent insider transactions for EyePoint, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
George Elston EYPT Common Stock Gift 64,953 64,953 20 Aug 2026 By GRAT
George Elston EYPT Common Stock Gift -66.6% -64,953 32,517 20 Aug 2026 Direct
George Elston EYPT Common Stock Other 5.45% 5,000 96,691 20 Aug 2026 Direct
George Elston EYPT Common Stock Other -16.7% -5,000 25,000 20 Aug 2026 By Family Trust
Karen L. Zaderej EYPT Common Stock Purchase 27.5% $52,258 $4.93 10,600 49,100 18 Aug 2026 Direct
Jay S. Duker EYPT Common Stock Tax liability -45.6% -8,059 9,594 10 Jul 2026 Direct
Jay S. Duker EYPT Common Stock Options Exercise 1690.4% 16,667 17,653 10 Jul 2026 Direct
Jay S. Duker EYPT Restricted Stock Units Options Exercise -100% -16,667 0 10 Jul 2026 Direct
Ramiro Ribeiro EYPT Common Stock Sale -100% $73,167 $15.01 -4,875 0 30 Jun 2026 Direct
Ramiro Ribeiro EYPT Common Stock Options Exercise 4,875 4,875 30 Jun 2026 Direct
Ramiro Ribeiro EYPT Stock Option (Right to Buy) Options Exercise -6.06% -4,875 75,563 30 Jun 2026 Direct
George Elston EYPT Common Stock Tax liability -3.81% -3,627 91,691 25 May 2026 Direct
George Elston EYPT Common Stock Options Exercise 8.54% 7,500 95,318 25 May 2026 Direct
George Elston EYPT Restricted Stock Units Options Exercise -100% -7,500 0 25 May 2026 Direct
Ramiro Ribeiro EYPT Common Stock Sale -100% $36,555 $15.00 -2,437 0 17 Apr 2026 Direct
Ramiro Ribeiro EYPT Common Stock Options Exercise 2,437 2,437 17 Apr 2026 Direct
Ramiro Ribeiro EYPT Stock Option (Right to Buy) Options Exercise -2.94% -2,437 80,438 17 Apr 2026 Direct
Jay S. Duker EYPT Common Stock Other 76.3% 76,766 177,431 23 Mar 2026 By Family Trust
Jay S. Duker EYPT Common Stock Other -98.7% -76,766 986 23 Mar 2026 Direct
Jay S. Duker EYPT Stock Option (Right to Buy) Other 150,000 97,500 23 Mar 2026 By Family Trust
Jay S. Duker EYPT Stock Option (Right to Buy) Other -95.1% -150,000 7,800 23 Mar 2026 Direct
Jay S. Duker EYPT Common Stock Purchase 1.51% $19,724 $13.15 1,500 100,665 16 Mar 2026 By Family Trust
Ramiro Ribeiro EYPT Common Stock Sale -100% $43,572 $17.87 -2,438 0 04 Mar 2026 Direct
Ramiro Ribeiro EYPT Common Stock Options Exercise 2,438 2,438 04 Mar 2026 Direct
Ramiro Ribeiro EYPT Stock Option (Right to Buy) Options Exercise -2.86% -2,438 82,875 04 Mar 2026 Direct
George Elston EYPT Common Stock Gift 20% 5,000 30,000 02 Mar 2026 By Family Trust
George Elston EYPT Common Stock Gift -5.39% -5,000 87,818 02 Mar 2026 Direct
Ramiro Ribeiro EYPT Common Stock Sale -100% $36,555 $15.00 -2,437 0 17 Feb 2026 Direct
Ramiro Ribeiro EYPT Common Stock Options Exercise 2,437 2,437 17 Feb 2026 Direct
Ramiro Ribeiro EYPT Stock Option (Right to Buy) Options Exercise -2.78% -2,437 85,313 17 Feb 2026 Direct
Nancy Lurker EYPT Common Stock Options Exercise 34.3% 75,133 294,346 06 Jan 2026 Direct
Nancy Lurker EYPT Restricted Stock Units Options Exercise -100% -75,133 0 06 Jan 2026 Direct
Jay S. Duker EYPT Common Stock Tax liability -11.4% -10,054 77,752 06 Jan 2026 Direct
Jay S. Duker EYPT Common Stock Options Exercise 31% 20,793 87,806 06 Jan 2026 Direct
Jay S. Duker EYPT Restricted Stock Units Options Exercise -100% -20,793 0 06 Jan 2026 Direct
George Elston EYPT Common Stock Tax liability -4.66% -4,487 91,852 06 Jan 2026 Direct
George Elston EYPT Common Stock Options Exercise 18.9% 15,285 96,339 06 Jan 2026 Direct
George Elston EYPT Restricted Stock Units Options Exercise -100% -15,285 0 06 Jan 2026 Direct
Ramiro Ribeiro EYPT Common Stock Sale -100% $727,319 $17.10 -42,544 0 05 Jan 2026 Direct
Ramiro Ribeiro EYPT Common Stock Options Exercise 220% 29,250 42,544 05 Jan 2026 Direct
Ramiro Ribeiro EYPT Stock Option (Right to Buy) Options Exercise -25% -29,250 87,750 05 Jan 2026 Direct
Jay S. Duker EYPT Common Stock Tax liability -17.8% -14,505 67,013 05 Jan 2026 Direct
Jay S. Duker EYPT Common Stock Options Exercise 58.2% 30,000 81,518 05 Jan 2026 Direct
Jay S. Duker EYPT Restricted Stock Units Options Exercise -50% -30,000 30,000 05 Jan 2026 Direct
George Elston EYPT Common Stock Tax liability -5.15% -4,403 81,054 05 Jan 2026 Direct
George Elston EYPT Common Stock Options Exercise 21.3% 15,000 85,457 05 Jan 2026 Direct
George Elston EYPT Restricted Stock Units Options Exercise -50% -15,000 15,000 05 Jan 2026 Direct
Nancy Lurker EYPT Common Stock Options Exercise 6.13% 12,666 219,213 05 Jan 2026 Direct
Nancy Lurker EYPT Restricted Stock Units Options Exercise -50% -12,666 12,667 05 Jan 2026 Direct
Ramiro Ribeiro EYPT Common Stock Tax liability -32.4% -6,373 13,294 03 Jan 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .